172 related articles for article (PubMed ID: 38681770)
1. A population-based prospective study on obesity-related non-communicable diseases in northern Iran: rationale, study design, and baseline analysis.
Motamed N; Zamani F; Maadi M; Ajdarkosh H; Roozafzai F; Keyvani H; Poustchi H; Shakeri R; Ashrafi GH; Perumal D; Rabiee B; Moradi-Lakeh M; Khoonsari M; Kheyri Z; Sohrabi MR; Doustmohammadian A; Amirkalali B; Safarnezhad Tameshkel F; Gholizadeh E; Hosseini SH; Karbalaie Niya MH
Front Endocrinol (Lausanne); 2024; 15():1329380. PubMed ID: 38681770
[TBL] [Abstract][Full Text] [Related]
2. The PERSIAN Guilan Cohort Study (PGCS).
Mansour-Ghanaei F; Joukar F; Naghipour MR; Sepanlou SG; Poustchi H; Mojtahedi K; Balou HA; Heidarzadeh A; Malekzadeh R
Arch Iran Med; 2019 Jan; 22(1):39-45. PubMed ID: 30821159
[TBL] [Abstract][Full Text] [Related]
3. The protocol of a population-based prospective cohort study in southwest of Iran to analyze common non-communicable diseases: Shahrekord cohort study.
Khaledifar A; Hashemzadeh M; Solati K; Poustchi H; Bollati V; Ahmadi A; Kheiri S; Samani KG; Banitalebi M; Sedehi M; Malekzadeh R
BMC Public Health; 2018 May; 18(1):660. PubMed ID: 29801446
[TBL] [Abstract][Full Text] [Related]
4. The effect of obesity phenotype changes on cardiovascular outcomes in adults older than 40 years in the prospective cohort of the Tehran lipids and glucose study (TLGS): joint model of longitudinal and time-to-event data.
Sedaghat Z; Khodakarim S; Sabour S; Valizadeh M; Barzin M; Nejadghaderi SA; Azizi F
BMC Public Health; 2024 Apr; 24(1):1126. PubMed ID: 38654182
[TBL] [Abstract][Full Text] [Related]
5. The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.
Hosseinpanah F; Tasdighi E; Barzin M; Mahdavi M; Ghanbarian A; Valizadeh M; Azizi F
PLoS One; 2020; 15(9):e0239164. PubMed ID: 32947607
[TBL] [Abstract][Full Text] [Related]
6. Obesity and loss of disease-free years owing to major non-communicable diseases: a multicohort study.
Nyberg ST; Batty GD; Pentti J; Virtanen M; Alfredsson L; Fransson EI; Goldberg M; Heikkilä K; Jokela M; Knutsson A; Koskenvuo M; Lallukka T; Leineweber C; Lindbohm JV; Madsen IEH; Magnusson Hanson LL; Nordin M; Oksanen T; Pietiläinen O; Rahkonen O; Rugulies R; Shipley MJ; Stenholm S; Suominen S; Theorell T; Vahtera J; Westerholm PJM; Westerlund H; Zins M; Hamer M; Singh-Manoux A; Bell JA; Ferrie JE; Kivimäki M
Lancet Public Health; 2018 Oct; 3(10):e490-e497. PubMed ID: 30177479
[TBL] [Abstract][Full Text] [Related]
7. Alarm of non-communicable disease in Iran: Kavar cohort profile, baseline and 18-month follow up results from a prospective population-based study in urban area.
Safarpour AR; Fattahi MR; Niknam R; Tarkesh F; Mohammadkarimi V; Boogar SS; Abbasi E; Abtahi F; Sivandzadeh GR; Ejtehadi F; Afshar M; Shamsnia SA; Niknejad N
PLoS One; 2022; 17(1):e0260227. PubMed ID: 35085244
[TBL] [Abstract][Full Text] [Related]
8. Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results.
Gandomkar A; Poustchi H; Moini M; Moghadami M; Imanieh H; Fattahi MR; Ayatollahi SM; Sagheb MM; Anushiravani A; Mortazavi R; Sepanlou SG; Malekzadeh R
Int J Public Health; 2017 Apr; 62(3):397-406. PubMed ID: 27349480
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of metabolically unhealthy obesity, overweight, and normal weight and the associated risk factors in a southern coastal region, Iran (the PERSIAN cohort study): a cross-sectional study.
Zoghi G; Shahbazi R; Mahmoodi M; Nejatizadeh A; Kheirandish M
BMC Public Health; 2021 Nov; 21(1):2011. PubMed ID: 34740348
[TBL] [Abstract][Full Text] [Related]
10. Cohort profile: the PERSIAN Dena Cohort Study (PDCS) of non-communicable diseases in Southwest Iran.
Harooni J; Joukar F; Goujani R; Sikaroudi MK; Hatami A; Zolghadrpour MA; Hejazi M; Karimi Z; Rahmanpour F; Askari Shahid S; Jowshan MR
BMJ Open; 2024 Apr; 14(4):e079697. PubMed ID: 38604628
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and correlates of low physical activity in the Iranian population: National survey on non-communicable diseases in 2011.
Sahebkar M; Heidarian Miri H; Noormohammadpour P; Akrami R; Mansournia N; Tavana B; Mansournia MA; Stamatakis E
Scand J Med Sci Sports; 2018 Aug; 28(8):1916-1924. PubMed ID: 29528518
[TBL] [Abstract][Full Text] [Related]
12. Non-communicable diseases in the southwest of Iran: profile and baseline data from the Shahrekord PERSIAN Cohort Study.
Ahmadi A; Shirani M; Khaledifar A; Hashemzadeh M; Solati K; Kheiri S; Sadeghi M; Mohammadian-Hafshejani A; Shahraki HR; Asgharzadeh A; Salehifard AZ; Mousavi M; Zarean E; Goujani R; Nazari SSH; Poustchi H; Dugué PA
BMC Public Health; 2021 Dec; 21(1):2275. PubMed ID: 34903205
[TBL] [Abstract][Full Text] [Related]
13. Dietary habits and the 10-year risk of overweight and obesity in urban adult population: A cohort study predicated on Yazd Healthy Heart Project.
Sarebanhassanabadi M; Shahriari Kalantari M; Boffetta P; Beiki O; Pakseresht M; Sarrafzadegan N; Mirzaei M; Kraemer A; Seyedhosseini S; Mali S; Namayandeh SM; Razavi SK; Alipour MR; Emami M; Ahmad Abad MS; Hosseini HA; Salehi-Abargouei A
Diabetes Metab Syndr; 2020; 14(5):1391-1397. PubMed ID: 32755840
[TBL] [Abstract][Full Text] [Related]
14. CA.ME.LI.A. An epidemiological study on the prevalence of CArdiovascular, MEtabolic, LIver and Autoimmune diseases in Northern Italy.
Bignotto M; Dei Cas M; Paroni R; Bianco E; Zermiani P; Gangale MG; Zadro V; Maregatti M; Piagnani A; Russo A; Baldassarre D; Folli F; Battezzati PM; Zuin M
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1416-1426. PubMed ID: 33814235
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of metabolic syndrome and its determinants among Iranian adults: evidence of IraPEN survey on a bi-ethnic population.
Jahangiry L; Khosravi-Far L; Sarbakhsh P; Kousha A; EntezarMahdi R; Ponnet K
Sci Rep; 2019 May; 9(1):7937. PubMed ID: 31138853
[TBL] [Abstract][Full Text] [Related]
16. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.
Eckel N; Li Y; Kuxhaus O; Stefan N; Hu FB; Schulze MB
Lancet Diabetes Endocrinol; 2018 Sep; 6(9):714-724. PubMed ID: 29859908
[TBL] [Abstract][Full Text] [Related]
17. Tabari Cohort Profile and Preliminary Results in Urban Areas and Mountainous Regions of Mazandaran, Iran.
Kheradmand M; Moosazadeh M; Saeedi M; Poustchi H; Eghtesad S; Esmaeili R; Alizadeh-Navaei R; Hedayatizadeh-Omran A; Nikaeein R; Rafiei A; Janbabaee G; Kashi Z; Sohrab M; Shirzad AhooDashti M; Afshari M; Golpour B; Aarabi M; Maleki I; Tirgar Fakheri H; Ghaemian A; Zarghami M; Ghaemi A
Arch Iran Med; 2019 Jun; 22(6):279-285. PubMed ID: 31356093
[TBL] [Abstract][Full Text] [Related]
18. Risk Classification for Metabolic Syndrome and the Incidence of Cardiovascular Disease in Japan With Low Prevalence of Obesity: A Pooled Analysis of 10 Prospective Cohort Studies.
Iso H; Cui R; Takamoto I; Kiyama M; Saito I; Okamura T; Miyamoto Y; Higashiyama A; Kiyohara Y; Ninomiya T; Yamada M; Nakagawa H; Sakurai M; Shimabukuro M; Higa M; Shimamoto K; Saito S; Daimon M; Kayama T; Noda M; Ito S; Yokote K; Ito C; Nakao K; Yamauchi T; Kadowaki T
J Am Heart Assoc; 2021 Dec; 10(23):e020760. PubMed ID: 34796738
[TBL] [Abstract][Full Text] [Related]
19. Gender-related differences in the prevalence of cardiovascular disease risk factors and their correlates in urban Tanzania.
Njelekela MA; Mpembeni R; Muhihi A; Mligiliche NL; Spiegelman D; Hertzmark E; Liu E; Finkelstein JL; Fawzi WW; Willett WC; Mtabaji J
BMC Cardiovasc Disord; 2009 Jul; 9():30. PubMed ID: 19615066
[TBL] [Abstract][Full Text] [Related]
20. Abdominal obesity phenotypes and risk of cardiovascular disease in a decade of follow-up: the Tehran Lipid and Glucose Study.
Keihani S; Hosseinpanah F; Barzin M; Serahati S; Doustmohamadian S; Azizi F
Atherosclerosis; 2015 Feb; 238(2):256-63. PubMed ID: 25540856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
